Sign in
CompletedEarly phase 1

The Effects of Chicken Extract and a Peptide Supplement for the Prevention of Cognitive Decline in Non-demented Elderly Adults

Key facts

Who runs it
Brand's Suntory Asia
Where
Taiwan3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Early phase 1
People taking part
276 people enrolled
Started
11 Dec 2020
Ended
8 Jan 2025
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Chicken extract supplement
  • Peptide Supplement
  • Placebo
Record updated
16 September 2025

Who can take part

Age
55 years to 75 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Male or female at 55 - 75 years of age
  • Baseline cognition:
  • Normal cognition with feelings of cognitive decline (subjective cognitive decline) OR
  • Mild cognitive impairment (MCI+) with memory impairment
  • Agree to participate in the study and provide written informed consent

Who cannot take part

  • Regular use of any medication in the past 6 months that may affect cognitive functioning
  • Subjects with excessive blood donation or blood drawn prior to baseline
  • Significant cerebrovascular disease
  • History of allergy to chicken meat
  • Diagnosis of Alzheimer's disease (AD) with dementia or any other dementia
  • Clinical dementia rating (CDR) score of > 0.5 at screening
  • Evidence of other neurological, psychiatric or physical illness that can produce cognitive deterioration per investigator's judgment
  • Current diagnosis or history of alcoholism or substance addiction
  • Persons with a history of cardiovascular disease or any other cardiovascular or cerebrovascular diseases which investigators deem unsuitable to participate in the clinical study
  • Inadequate visual and auditory acuity to allow neuropsychological testing
  • Inability or unwillingness to undergo PET scan
  • Regular use of cognitive enhancing supplements in the past 6 months

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This trial investigates the effect of a chicken extract supplement and a peptide supplement on cognitive function and potential mechanisms of action of cognitive decline during ageing, among non-demented elderly adults using a three-arm, randomized, placebo-controlled clinical trial design.

The 3 groups in the trial

  • Chicken extract supplementTreatment being tested
  • Peptides supplementTreatment being tested

    Treatment: Peptide Supplement

  • PlaceboPlacebo, for comparison

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Trial of A Chicken Extract and Peptide Supplement for the Prevention of Cognitive Decline and Mechanisms of Action in Non-demented Elderly Adults: A Multicenter, Two-year, Three-arm, Randomized, Double-blind, Placebo-controlled Study
Record updated
16 September 2025